The Metabolic Activity of the Spleen and Bone Marrow in...

25
1 The Metabolic Activity of the Spleen and Bone Marrow in Patients with Acute Myocardial Infarction Evaluated by 18 F-FDG PET Imaging Kim et al.: Activation of the spleen and bone marrow in AMI Eung Ju Kim, MD, PhD; 1 Sungeun Kim, MD, PhD; 2 Hong Seog Seo, MD, PhD; 1 Dong Oh Kang, MD 1 1 Cardiovascular Center, Division of Cardiology, Department of Internal Medicine; 2 Nuclear Medicine, Korea University Guro Hospital, Korea University College of Medicine, Seoul, Korea Correspondence to Hong Seog Seo, MD, PhD Division of Cardiology, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, 80 Guro-dong, Guro-gu, Seoul 152-703, Korea Tel: 82-2-2626-3018, Fax: 82-2-863-1109 Email: [email protected] DOI: 10.1161/CIRCIMAGING.113.001093 Journal Subject Codes: [4] Etiology: acute myocardial infarction; [32] Diagnostic testing: nuclear cardiology and PET; [134] Atherosclerosis: pathophysiology al Med ed ed ed ed ed edic ic ic ic ic ic icin in in in in in ine; e; e; e; e; e; e; M e n Seo MD PhD Me e e e edi di di i ic ci c c ne, Ko Ko Ko K rea a Univ er sity G uro Hosp ital l l, K K Kore a a a Univ v iv v ve ersity ty Colle e ge ge ge of Medi cin ea a a a ndence to Se Se Seo o o M M MD D D P P PhD hD hD by guest on June 5, 2018 http://circimaging.ahajournals.org/ Downloaded from

Transcript of The Metabolic Activity of the Spleen and Bone Marrow in...

Page 1: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

1

The Metabolic Activity of the Spleen and Bone Marrow in Patients with Acute

Myocardial Infarction Evaluated by 18F-FDG PET Imaging

Kim et al.: Activation of the spleen and bone marrow in AMI

Eung Ju Kim, MD, PhD;1 Sungeun Kim, MD, PhD;2

Hong Seog Seo, MD, PhD;1 Dong Oh Kang, MD1

1Cardiovascular Center, Division of Cardiology, Department of Internal Medicine;

2Nuclear Medicine, Korea University Guro Hospital, Korea University College of Medicine,

Seoul, Korea

Correspondence to Hong Seog Seo, MD, PhD Division of Cardiology, Department of Internal Medicine, Korea University Guro Hospital, Korea University College of Medicine, 80 Guro-dong, Guro-gu, Seoul 152-703, Korea Tel: 82-2-2626-3018, Fax: 82-2-863-1109 Email: [email protected]

DOI: 10.1161/CIRCIMAGING.113.001093

Journal Subject Codes: [4] Etiology: acute myocardial infarction; [32] Diagnostic testing:

nuclear cardiology and PET; [134] Atherosclerosis: pathophysiology

al Medededededededicicicicicicicininininininine;e;e;e;e;e;e;

M

e

nSeo MD PhD

Meeeeedididiiiccicc ne, KoKoKoK rea a Univvere sityyy GGGuro Hospppitalll, KKKoreeea aa Univvivvveersitytyy Colleeegegege of Medidd cin

eaaaa

ndence to SeSeSeooo MMMDDD PPPhDhDhD by guest on June 5, 2018

http://circimaging.ahajournals.org/

Dow

nloaded from

Page 2: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

2

Abstract

Background—Atherosclerosis is considered to be an inflammatory disease associated with the

activation of hematopoietic and immune-related organs such as the bone marrow (BM) and

spleen. We evaluated the metabolic activity of those organs and of the carotid artery with 18F-

FDG PET in patients with coronary artery disease, including acute myocardial infarction (AMI).

Methods and Results—Whole-body combined 18F-FDG PET/CT was performed in 32 patients

with AMI, 33 patients with chronic stable angina, and 25 control subjects. The mean standard

uptake value (SUV) was calculated in the regions of interest in the spleen and the BM of lumbar

vertebrae. The target-to-background ratio (TBR) of the SUVs of the carotid artery and jugular

vein was also calculated. In patients with AMI, the SUVs of the BM (1.67±0.16) and spleen

(2.57±0.39), as well as the TBR of the carotid artery (2.13±0.42), were significantly higher than

the corresponding values of patients with angina (1.22±0.62; 2.03±0.35; 1.36±0.37, all p<0.001)

and controls (0.80±0.44; 1.54±0.26; 1.22±0.22, all p<0.001) independent of traditional

cardiovascular risk factors and high-sensitivity CRP (hsCRP). In all groups combined, the TBR

of the carotid artery was significantly associated with the SUVs of the BM (r=0.535, p<0.001),

spleen (r=0.663, p<0.001), and hsCRP (r=0.465, p<0.001).

Conclusions—The metabolic activity of the BM and spleen as well as of the carotid artery was

highest in patients with AMI, intermediate in patients with angina, and lowest in control subjects.

The activation of the BM and spleen was significantly associated with inflammatory activity of

the carotid artery.

Keywords: spleen, bone marrow, coronary artery disease, positron emission tomography

Basic biological and clinical research supports the role of inflammation in the initiation, growth,

leen and the BM ofofofofofofof l

e carorotitititititit dddddd d arartttttetet ryryyyyyy aandndndndndndnd jj

a

) e

<

o d

l i k f t d hi h iti it CRP (h CRP) I ll bi d th

alsooooo cacacacacalclcclcculululululataa eddddd.. In patients with AMI, ttttthehehehh SUVs of tttheh BBBBBMMMM (1.67±0.16) and

),,, aaaaas well as thhhee TBBBRR ofofofofof the carrrottid arrrterrry (2.131313±0±0±0±± .42)2), weeerrre sssssigggngg ificici aaantttlyyy hiiiiggghe

ondinii g g values off fff patititiiients iiwiiith angiini a (1111 22.22±2±2±2 0.0000 6262626262; 222.22 03030300 ±0±0±0±± 33.3555; 1.333336±6±6±6±6±0.3737373 , allllllll p<<<<

ols (((0.80±0.44;; 1.54±0.26;; 1.22±0.22,, all pp<0.001) )) iiinii depepeepeenndnnn ent of trad

lll iii kkk fff t ddd hihihi hhh iii iiti iiit CCCRPRPRP (((hhh CRCRCRP)P)P) III llllll bbbiii ddd hhth by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 3: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

3

and rupture of atherosclerotic plaques.1 At every stage of atherosclerosis, monocyte-derived

macrophages are the principal mediators of inflammation.2, 3 Recent studies lend some clarity to

the role of inflammation in driving the atherogenic response to hypercholesterolemia and suggest

that this process is initiated in the bone marrow (BM) and spleen.4-6 In response to

hypercholesterolemia, both the BM and spleen overproduce inflammatory monocytes that enter

the circulation, accumulate in lesions, and differentiate into macrophages.7

Acute myocardial ischemic injury8 and infarction (AMI)9 activate the sympathetic

nervous system and trigger a cascade of hematopoietic stem and progenitor cell (HSPC)

proliferation in the BM and emigration to the spleen, as well as peripheral monocytosis.7 In this

process, the spleen acts as an extramedullary hematopoietic reservoir producing inflammatory

monocytes that aggravate atherosclerosis.8 Thus, this inflammatory linkage between the BM,

spleen and blood following an acute cardiac event may intensify the chronic inflammatory

process involved in atherosclerosis, independently from the primary myocardial wound site.7

This mechanism of systemic inflammation in atherosclerotic disease initiated by the BM and

spleen has been studied in animal models, but not in humans with coronary artery disease (CAD).

Activated inflammatory cells express high levels of glucose transporters and accumulate

18F-fluorodeoxyglucose (18F-FDG).10, 11 For this reason, 18F-FDG positron emission tomography

(PET) is a useful noninvasive imaging technique to evaluate the inflammatory status of

atherosclerotic plaques12_ENREF_11 and periodontal disease.13_ENREF_16 Theoretically, the

metabolic activity of the BM and spleen can be also evaluated by PET using 18F-FDG.10, 11

This study has 3 objectives: (1) to determine whether the metabolic activation of the BM

and spleen is associated with AMI; (2) whether the degree of metabolic activation of these

organs is associated with inflammatory activity at carotid plaques remote from the coronary

enitor cell ((((HSPCC) ) ) ) ) ) )

eral mmononococ tytytttttososiss.7777777 IIIIIIInn

e o

M

v e

i f t i i fl ti i th l ti di i iti t d b th BM

e splplplplpleeeeeeeeeenn n acacacaca ttst aaaaasss an extramedullary hemattattatopopopoo oietic reservovv ir ppprpp oducing inflammato

ttthtt aaataa aggravateee aathererosclclclclcleerosiiis.8 TThusss, this inflflflflflamamamamammammmm toorry linnnkkkagegegegg betweweweeeen thee BBBM

blooddddd fffff lllolollloll wiiingggg an acute cardiac event may intttett nsififififify thththththe hhchronic iini fflf ammatott ry

volved in atherosclerosiiis,, indddeppendedd ntlylyy from the prp imary y y mymmymm ocarararrrddiddd al wound site

iii fff t iii iii ffflll tiii iii hhth lll tiii dddiii iii iiitiii t ddd bbb thhh BBBMMM by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 4: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

4

arteries, and (3) whether the activity in the BM and spleen is higher in patients with chronic

stable angina (CSA) than in control subjects. We measured 18F-FDG uptake in the spleen, BM,

and carotid artery using whole-body 18F-FDG-PET/computed tomography (CT) in patients with

AMI, CSA, and control subjects without a history of CAD.

Methods

Study Subjects

Between June 2008 and March 2009, we prospectively recruited patients at Korea University

Guro Hospital who were diagnosed with AMI or CSA. AMI was defined as typical changes in

biochemical markers of myocardial necrosis along with at least 1 of the following: ischemic

symptoms, electrocardiographic changes indicative of new ischemia, development of pathologic

Q waves, or imaging evidence of new loss of viable myocardium or new regional wall motion

abnormalities.14 CSA was defined as the presence of stable anginal symptoms for at least 6

months with at least 50% luminal narrowing in at least 1 major coronary artery on angiography.

Criteria for exclusion from the control group were a history of cardiovascular disease

(myocardial infarction, unstable angina, stroke, or cardiovascular revascularization), greater than

stage 1 hypertension (resting blood pressure 160/100 mmHg), uncontrolled diabetes mellitus

(glycated hemoglobin >9%), malignancy, or severe renal or hepatic disease. Subjects with a

history of an inflammatory condition, or those taking inflammation-modulating medications

within the prior 6 months, were excluded from the study. All participants provided written

informed consent and the Korea University Institutional Review Board approved this study

protocol.

The following clinical and demographic parameters were recorded: age, sex, body mass

index, waist circumference, the presence of hypertension (defined as those taking

fined as tyyyyyypippp cal chchchhchhhananaaaaa

of thhhhhhhe e ffffffofollllllllllllllowowininiiiii g:g:g:g:g:g: iiiiiiissc

h

o m

i l

t g

l i f th t l hi t f di l d

ellececececectrtrtrtrtrococcoccarararara didd ogogogggrrar phic changes indicative ee ofoo new ischemimm a, ddddevelopment of path

orrr rr iiimii aging evvviddencecce offfff nnew llloll ss of viiablelele mmmyoyoyoyoyoccacacac rrdiuumm orrr newewewee regggioooonaaall waallllll m

ies.14141411 CCCCCSASASASASA was ddd ffefiiini ed as the presence of tttstt bbablllell angin llal sym ttttptoms fffor attt l

th at least 50% llluminal ll narrowing g in at least 1 majojj r corororooonnnaryy aaaaarrtrrr ery y on anggiogg

lll iii fff hhth t lll hhhiii t fff dididi lll ddd by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 5: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

5

antihypertensive medications or 2 blood pressure recordings over 140/90 mmHg), the presence

of diabetes mellitus (defined as those undergoing treatment with diet and/or medications or a

fasting serum glucose >126 mg/dl), and dyslipidemia (defined as those taking lipid-lowering

medications or a fasting serum total cholesterol 240 mg/dl, triglycerides 200 mg/dl, high

density lipoprotein cholesterol <40 mg/dl, or low density lipoprotein cholesterol 160 mg/dl).

Cardiac troponin T and creatine kinase-MB fraction (CK-MB) were measured using

electrochemiluminescence immunoassays on the Elecsys 2010 analyzer (Roche Diagnostics,

Indianapolis, Inidiana, USA). Concentrations of troponin T >0.1 ng/mL and CK-MB >6.73

ng/mL in men or >3.77 ng/mL in women were used as cutoff values to diagnose AMI based on

the manufacturer’s instructions.

18F-FDG- PET/CT Imaging

18F-PET/CT was performed using the Gemini TF 16-Slice PET/CT scanner (Philips Medical

Systems, Cleveland, Ohio, USA). Patients diagnosed with AMI, all of whom were successfully

treated by primary percutaneous coronary intervention, underwent PET/CT within 10 days of the

event when they were clinically stable (mean: 6.3 days; range: 1-10). The TF scanner is a new

high-performance, time-of-flight-capable, fully 3-dimensional PET scanner that uses lutetium-

yttrium oxyorthosilicate crystals.15 After at least 12 hours of fasting, FDG (5.19 MBq/kg) was

injected intravenously, after which patients rested in a quiet room for 60 minutes. In diabetic

patients, who may have a different blood clearance from nondiabetic patients, we determined

blood glucose level before 18F-FDG administration and changed the PET schedule if it exceeded

180 mg/dl to reduce the metabolic effect on FDG uptake. Whole-body PET images (from below

the cerebellum to the inguinal region) were acquired for 10 minutes (1 minute per bed position).

ngggg/mL and CK-MMMMMMMBBBBBBB

to ddddddiiiiaiaii gngnosose e AMAMAMAMAMAMAMIIII II I babbbbbab

a

P

T M

C

i t i t ti d t PET/CT ithi 10 d

acturururururererererer’s’s’ss iiinsnnsnsn trucucucuu titt ons.

PPPPPETTTETT/CT Imaginiing

T was ppperform ddeddd u iisiiinggggg ttttthhehhh Gemiiniii i iiii FTFF 11166-6 SlSlSlSlSliiciii e PEPEPEPEPET/T/T/T/T/CTCTCT scanner (PhPhPhililillipii s MMM

Cleveland,, Ohio,, USA))). Patiiients diaii gng oseddd with AMI,, allllllll of whhhhhdd ooomoo were succe

iii t iii t iiti ddd t PEPEPET/T/T/CTCTCT iiithihihi 101010 ddd by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 6: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

6

Analysis of Positron Emission Tomography Images

PET images were analyzed on a dedicated workstation (Extended Brilliance Workspace 3.5;

Philips). Right carotid FDG uptake was measured along the length of the right carotid vessel,

starting at the bifurcation and extending inferiorly and superiorly every 4 mm for a total of 8

consecutive PET/CT images for each subject. Arterial FDG uptake was quantified in the region

of interest (ROI) around each artery on every slice of the co-registered transaxial fusion PET/CT

images. The highest standard uptake values (SUVs) of the ROIs of all 8 slices within the right

carotid artery were averaged together for each subject. Next, the arterial SUV was divided by the

blood-pool SUV measured from the jugular vein for normalization. In this way, the arterial

target-to-background ratio (TBR) was calculated for each subject. 18F-FDG uptake was measured

in the spleen by placing an ROI around the organ on all transaxial slices. The highest SUVs from

all transaxial slices were recorded and their average was used as the mean SUV for the entire

organ. BM 18F-FDG uptake was calculated under CT-guided anatomical reference from the third

to fifth lumbar vertebrae,16 and the average of the highest SUVs was used as the mean SUV for

analysis. To determine the variability of the mean SUV measurements, images from 20 subjects

were analyzed twice, several weeks apart, by 2 readers who were unaware of the subjects’

clinical histories. The intra- and inter-observer correlation coefficient values of the mean SUV

measurements were greater than 0.9.

Statistical Analysis

Baseline characteristics of the participants were analyzed according to the 3 main study groups.

Frequencies and proportions were reported for categorical variables, and either mean ± standard

deviation or median with interquartile range were reported for continuous variables based on

normality of distribution. The Pearson chi-squared test, Fisher’s exact test, one-way analysis of

ial SUV was dividededededededed dddddd

n. In n thththththththiisiiiiis wwayayyyyyy,, ththththththheeee eee a

a e

e V

i e

h

b t b 16 d th f th hi h t SUV d th SU

ackkkkkgrgrgrgrgrouououououndndndndnd rrratioioioii (TBR) was calculated forororrr eeeach subject..t 18F-F-F-FF FFDFF G uptake was me

ennn nn bbbybb placing aaann ROROROI arrroounddd tttheee oorgananan onnn all trtrrrrananananansaxiiaal sliiiceees..... TThe hhhigggghhhessst SUVUU

ial slililiiicecees were recordddedd d andd ddd theiiir averaggggge was used as thththe mean SSSSSUVVV ffffor ttthhheh

18F-FDG upptake was calcullal ted dd under CT-gguided anatommmmmiiicii al refefefffeerence from th

bbb t bbb 161616 ddd thhh fff hhth hihihi hhh t SSSUVUVUV ddd hhth SSSUUU by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 7: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

7

variance (ANOVA), and the Kruskal-Wallis test were used to compare variables between groups.

Subsequent comparisons were performed by Bonferroni’s post-hoc test, or the Mann-Whitney U-

test or Fisher’s exact test with Bonferroni corrected p values. The SUVs of the BM and spleen

and the TBRs of the carotid artery were compared between the 3 groups using analysis of

covariance (ANCOVA) with Bonferroni multiple comparisons, in which the possible

confounding effects of sex, waist circumference, hypertension, diabetes, dyslipidemia, smoking,

statin use, and high-sensitivity C-reactive protein (hsCRP) were taken into account by including

them in the model as covariates. Spearman correlation analysis was performed to identify the

relationship between 18F-FDG uptake in multiple organs and hsCRP. Multiple linear regression

analyses using the TBR of the carotid artery as a dependent variable were also performed to

investigate whether there was an independent relationship between 18F-FDG uptake in each

organ and uptake in the carotid artery. Data were analyzed using SPSS for Windows version 20.0

(SPSS, Chicago, IL, USA). P-values less than 0.05 were considered statistically significant.

Results

Clinical and laboratory characteristics

The subjects included 51 men (56.7%) and 39 women (43.3%). Women comprised the majority

of the control group, while men comprised the majority of the CSA and AMI groups. The mean

age of subjects was 57.7±10.1 years, and did not differ significantly between groups. Compared

to the control group, most of the traditional cardiovascular risk factors, such as hypertension,

diabetes, dyslipidemia, and smoking, were more prevalent in the CSA and AMI groups. The

prevalence of those risk factors was not significantly different between the CAD groups.

Subjects taking statins comprised nearly a third of total subjects in both CAD groups upon initial

presentation. There were significant stepwise increases in white blood cell count and hsCRP

s pperformed to iddenenenenenenentti

Mululllltitittitititi lplplllllee lililililililineneara rrrrrrreeeegegee r

si the TBR of the carotid arte as a de ndent variable were also erform

n

u o

i t

R lt

singgnggg ttttthehehehehe TTTTTBRBRBRRR ooof the carotid artery as a a aaa dddependent vavav riabababababllell were also perform

whwhwhwhwhether therrre wass annnnn independnndennnt relatttionnnshshshipipipipip beetwweenn 1888FF-FDG GG GG upupuptakkkek in

uptakekkekk iiiiin the carotititiddd arteryyyyy. DDaDDD ta were analllyzeddddd usiiing SPSPSPSPSPSSSSSS ffffor WWWWWiniiii dows ver iisiio

icagog , , IL, , USA))). P-values less thhhan 0.05 were consideredded ssssstttat tisticicicaalaaa lyyy sigggnificant

RR llt by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 8: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

8

from the control group to the AMI group (Table 1).

Comparison of FDG uptake in the bone marrow, spleen, and carotid artery between groups

The mean maximum SUV levels in the spleen and BM were incrementally and significantly

higher in the AMI and CSA groups compared to the control group (Table 1, Figure 1A, Figure

2A, and Figure 2B). The AMI group had higher carotid artery TBRs than did the CSA and

control groups (Table 1, Figure 1B, and Figure 2C). Although the carotid artery TBR of the CSA

and control groups did not differ significantly (Table 1 and Figure 2C), it reached statistical

significance after adjusting for sex, waist circumference, hypertension, diabetes, dyslipidemia,

smoking, statin use, and hsCRP in ANCOVA analysis (for the carotid artery TBR, AMI vs. CSA

group, p<0.001; CSA vs. control group, p=0.038). The SUVs of the spleen and BM were also

significantly different between groups after the same adjustments (for spleen SUV, AMI vs. CSA

group, p<0.001; CSA vs. control group, p<0.001, for BM SUV, AMI vs. CSA group, p=0.003;

CSA vs. control group, p=0.017).

Correlation between high-sensitivity C-reactive protein and FDG uptake in the bone marrow,

spleen, and carotid artery

The TBR of the carotid artery and SUVs of the BM and spleen correlated significantly with each

other in study subjects overall. Without adjustment, the TBR of the carotid artery was most

highly correlated with the SUV of the spleen. HsCRP was also significantly correlated with FDG

uptake in the BM, spleen, and carotid artery (Table 2). In the AMI group, there was no

correlation between peak serum CK-MB and troponin-T levels and FDG uptake in the BM,

spleen, or carotid artery (data not shown).

on,, diabetes,, dysyslililililililipipippppp d

arteeryryyyyyy TTTTTTTBRBRBRBRBRBRBR, AMAMAMAMAMAMAMIIII I II vsv

0 r

l s

.001; CSA vs. control group, p<0.001, for BM SUV, AMI vs. CSA group, p=

b t hi h iti it C ti t i d FDG t k i th b

0.00101010101;;;;; CSCSCSCSCSAA AAA vsssss... control group, p=0.038).)) TTThe SUVs ofofo theheehee spleen and BM wer

lyyy yy dddidd fferent betwttweeeen grouoouoo ps affftff errr tthe samameee adjujujujjustststss memmemm ntts (forrr ssspllllleen SUSUSUUUV,V,V, AAAMMMI vs

.00111; CSCSCSCSCSAAA AA vs. co ttntrol grgggg oup, p<0<0<000 0.00000100 , fffor BMBMBMBMBM SSSSSUVUVUVUVUV, AMAMAMAA III vs. CSCSCSCSCSAA A group, p=

ntrol grg oup,p, pp=0.017).))

bbb t hhhi hhh iti it CCC ti t i ddd FDFDGGG t kkk i hhth bbb by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 9: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

9

Relationship between carotid artery target-to-background ratio and bone marrow FDG uptake,

spleen FDG uptake, and high-sensitivity C-reactive protein

Multiple linear regression analysis of the overall study population, which included age, sex,

waist circumference, hypertension, diabetes, dyslipidemia, smoking, and statin use as covariates,

revealed an independent relationship between carotid artery TBR, the SUVs of the spleen and

BM, and hsCRP. The SUVs of the spleen and BM were significantly associated with carotid

artery TBR even after further adjustment for hsCRP. In contrast, hsCRP did not maintain a

significant association with carotid artery TBR when the SUV of the BM or spleen was entered

into the model as an independent variable (Table 3).

Discussion

This study revealed significant associations between CAD, the metabolic activity of the spleen

and BM, and the inflammatory activity of the carotid artery independent of traditional

cardiovascular risk factors and hsCRP level. Those activities were highest in patients with AMI,

intermediate in patients with CSA, and lowest in the control group. The 18F-FDG uptake in the

carotid artery was significantly associated with the metabolic activity of the spleen and BM as

well as with hsCRP level.

Most studies that support the association between inflammation and CAD have been

based on epidemiologic analysis of circulating biomarkers17-19 and animal experiments.20-23

Recent studies have identified that the role of the spleen and BM in chronic and acute

inflammation in atherosclerotic disease. In chronic inflammation of atherosclerosis, both the BM

and spleen are involved. HSPCs progressively relocate from the BM to the splenic red pulp,

where they clonally expand with granulocyte macrophage colony-stimulating factor and

interleukin-3 and differentiate into inflammatory monocytes.5 Monocytes born in the spleen

BM or sppppppleen wwasasasasasasas e

and the inflammatory activity of the carotid artery independent of trad

u h

t i ti t ith CSA d l t i th t l Th 18F FDG t k

Discussisisiiionononoo

rrrrrevvvvvealed signnnifficanaantt assssssosociatttiiioii nsnns beeetwwweeeennn CAAAAAD,D,D,D,D, tthee mmetabababollicicicii activivivvitii yyy of tthhhehh

and thththththe inflflfflf ammatttoryyyyy a tttcttivity foffff thehh car tttottidididdd arttttery iiindddepe dnddddent tt ffoff tttraddd

ular risk factors and hsCRP level. Thoh se activities were hihihihihighghghest tt ininininin ppatients with

t iii iiti t iiithhh CSCSCSAAA ddd lll t iii hhth t lll TTThhh 181818FFF FDFDFDGGG t kkk by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 10: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

10

intravasate, circulate, and accumulate into atherosclerotic lesions in murine models.5_ENREF_24

Our findings are consistent with this knowledge, in that significantly higher activity was found in

the BM, spleen, and carotid artery in the CSA group than in the control group.

Using 18F-FDG PET, Assmus et al. found significantly higher metabolic activity in the

BM and significantly larger populations of hematopoietic CD34+ and CD133+ cells in BM

aspirates from patients within 7 days after AMI than in patients with chronic post-ischemic heart

failure.24 The same authors reported that AMI induced by ligating a coronary artery or

application of other stressors can activate stem cells in the BM in non-atherosclerotic mice.24 It

has also been reported that acute ischemic myocardial injury triggers emergency hematopoiesis

in the BM and spleen,7 and that AMI liberates HSPCs from BM niches via signals from the

sympathetic nervous system.9_ENREF_25 The progenitors then seed the spleen and yield a

sustained boost in monocyte production to meet demand in the infarcted myocardium.7, 9 This

process, however, may have unintended consequences, such as acceleration of underlying

atherosclerosis triggering reinfarction or stroke.7, 9 Dutta et al. found that in ApoE-/- mice, AMI

accelerates underlying aortic atherosclerosis.9

In light of these findings, our AMI group indeed demonstrated higher metabolic activity

in the spleen and BM than the CSA group. The greater inflammatory activity in the carotid

arteries of the AMI group compared to the CSA group may be evidence of this damaging

accumulation of monocytes in atherosclerotic lesions. Moreover, we found that the metabolic

activity of the carotid artery was closely associated with that of the spleen and BM as well as

with the level of hsCRP in the overall patient population. These findings suggest that the

inflammatory status of atherosclerosis is influenced by systemic inflammation modulated by the

spleen and BM.

on-atherosclerotic c mimimmmmm c

s emmerergegencncy y hehhhhhhemamamamamaamatototototototop

o

c y

b

o e

i t i i i f ti t k 7 9 D tt t l f d th t i A E / i

annnnnd dd dd spspspspspleleleleleenenen,7 aaand that AMI liberates HSHSHSHHSPPPCs from BBBM ninininin ches via signals fro

cc cc c nnnenn rvous systsstememm.9___ENRNRNRNN EFF_2555 Thhhe prroogggenininin tototototorrrsrr thhenn seeeeeed thheh splplpllleeeeeen annddd dd y

boost tt iiniinin monocytytytty e productiitiition to meet ddddemanddddd in the iiiii ffnfarcteddddd myoca ddrddiuii m.7, 7777

owever,, may y hahh ve unintended dd consequq ences,, such asss accelllerererereration of unde

iii t iii iii iii fff tiii t kkk 777 999 DD tt t lll fff ddd thhh t iii AAA EEE /// iii by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 11: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

11

Metabolic activation of the major organs that harbor inflammatory cells such as the

spleen,8 or that participate in inflammatory cell production, such as the BM and spleen,5, 9 has

been revealed using 18F-FDG-PET in a variety of systemic conditions, including infection,25

cancer,16 connective tissue diseases26 and systemic autoimmune disorders.27 However, few

studies have demonstrated the metabolic activation of the BM and spleen in humans with CAD.

To the best of our knowledge, this is the first in vivo human study showing the metabolic activity

of the spleen and BM in patients with CAD using a molecular imaging tool.

In our study, the metabolic activity of the spleen and BM was high in patients with AMI

even after a mean of 6.3 days from the event. Inflammatory monocytes, which have been found

to be chronically expanded in the blood pool of atherosclerotic apoE-/- mice, impair infarct

healing through prolonged presence in the infarct and deregulated resolution of inflammation.28

This result suggests that patients with AMI who have underlying inflammation associated with

atherosclerosis may have prolonged activation of the organs involved in inflammation. Further

studies are needed to determine the time period during which activation of the spleen and BM

persists after AMI in humans.

Our study has several limitations. First, its cross-sectional design, small sample size, and

significant differences between subjects and controls may have introduced various levels of bias.

Although we attempted to adjust for these differences and the small sample size, our model may

not be sufficiently powered to support the results. Second, we did not perform coronary

angiography in the control group to confirm the presence of coronary atherosclerosis and this

may have affected our results. Third, we did not perform histopathological analysis of tissue

samples from the spleen or BM. However, it is already known that 18F-FDG accumulates in

tissue macrophages and its intensity correlates with the staining density of tissue macrophages in

s highg in pappppp tients wwwwwwwititiiiii h

tes, whwhhhhhhiciciiiii hhh hhhh hhahahhhh veve bbbbbbbeeeeeeeeeeeeeen n

n

o a

e

o F

d d t d t i th ti i d d i hi h ti ti f th ld

nicacacacacallllllllyyy yy exexexexexpppandndndnn edee in the blood pool offf atttheroscleroticii aaaaapopopoppoE-/- mice, impair fffff

ooooougugugugugh prolongeeedd prrreesennncecece in thththththeee iinfaaarccct aaand dedededd rerererereguggugg laateed reeesoluuuuuttit on ooof ff ff innnffflammmmma

suggesesstttstt thattt papp tititientttst wititititithhhhh AMIII hwhhhho hahhh ve u dndddderlllyll ing iiinffflllamm tttattiioiii n associii ttate

osis may y have pprolongged activation offf the orggans inv lololveveveveved in iiiiinnfnnn lammation. F

ddd ddd t ddd t iii hhth iiti iii ddd ddd iii hhhiii hhh iiti iiti fff hhth lllddd by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 12: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

12

corresponding histological sections of specimens.10, 11 Fourth, the patients with AMI may have

had elevated levels of catecholamines and endogenous steroids associated with stress in addition

to their underlying inflammatory state. However, we were not able to control for all factors

affecting glucose metabolism and FDG uptake, including levels of insulin, catecholamines,

steroids, and other substrates in plasma, which may have affected our results. Fifth, we did not

control for other factors affecting systemic inflammation, such as life style habits, low-grade

chronic infections, and genetic predisposition. Finally, we did not measure the biomarkers of

HSPC in the BM or monocyte subsets in the peripheral blood. In short, this study was not

designed to definitively prove an etiological hypothesis, but was an observational study designed

to measure metabolic activity of the spleen and BM in patients with CAD as an indirect probe

into a previously established condition.

In conclusion, the metabolic activity of the BM and spleen as well as of the carotid artery

was highest in patients with AMI, intermediate in patients with CSA, and lowest in controls. The

relationship between those parameters and CAD status was independent of traditional

cardiovascular risk factors. Activation of the BM and spleen was closely associated with the

activity in the carotid artery. Our results offer insights into risk stratification, monitoring of

therapy, and physiological changes in the early stages of atherosclerosis, when intervention may

be most effective.

Sources of Funding

This study was partly supported by the Korea Institute of Science and Technology Institutional

Program (Project No. 2E24080); a grant from the Korean Health Technology R&D Project of the

Ministry for Health, Welfare & Family Affairs of the Republic of Korea (A070001); and a grant

from the Korea University-Korea Institute of Science and Technology (KU-KIST) Graduate

short,, this study y y y y y y wwwwwww

bservvatattttioioiiiii nanalllllll tststtttt dududdy y yyyyy dddddeded

metabolic activit of the s een and BM in tients with CAD as an indirect

i

conclusion, the metabolic activity of the BM and spleen as well as of the carotid

t l

b t th t d CAD t t i d d t f t d

mmmmmetetetee abababababolololoo icicicicic actctctcc ivivivity of the spleen and BMBMBMMM in patients with hhhh CAD as an indirect

ioououoo slsss y establisssheed cocconditititii iiioii n.

conclllussiioioiion, thehhhh mettt bbabbbolic a tttcttivity foff ttttthhheh BBBMMM andd ddd splllell en as well as off thehhh car ttotidididi

t in ppatients withhh AMI, , intermedddiate iin ppatieii nts with CSAAAAA, , and lololooowest in controln

bbb t thhh t ddd CCCADADAD t t iii ddd ddd t fff t ddd by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 13: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

13

School Converging Science and Technology(R1106223).

Disclosures

None.

References 1. Greaves DR, Channon KM. Inflammation and immune responses in atherosclerosis.

Trends Immunol. 2002; 23:535-541 2. Jonasson L, Holm J, Skalli O, Bondjers G, Hansson GK. Regional accumulations of t

cells, macrophages, and smooth muscle cells in the human atherosclerotic plaque. Arteriosclerosis. 1986; 6:131-138

3. van der Wal AC, Das PK, Bentz van de Berg D, van der Loos CM, Becker AE. Atherosclerotic lesions in humans. In situ immunophenotypic analysis suggesting an immune mediated response. Lab Invest. 1989; 61:166-170

4. Yvan-Charvet L, Pagler T, Gautier EL, Avagyan S, Siry RL, Han S, Welch CL, Wang N, Randolph GJ, Snoeck HW, Tall AR. Atp-binding cassette transporters and hdl suppress hematopoietic stem cell proliferation. Science. 2010; 328:1689-1693

5. Robbins CS, Chudnovskiy A, Rauch PJ, Figueiredo JL, Iwamoto Y, Gorbatov R, Etzrodt M, Weber GF, Ueno T, van Rooijen N, Mulligan-Kehoe MJ, Libby P, Nahrendorf M, Pittet MJ, Weissleder R, Swirski FK. Extramedullary hematopoiesis generates ly-6c(high) monocytes that infiltrate atherosclerotic lesions. Circulation. 2012; 125:364-374

6. Murphy AJ, Akhtari M, Tolani S, Pagler T, Bijl N, Kuo CL, Wang M, Sanson M, Abramowicz S, Welch C, Bochem AE, Kuivenhoven JA, Yvan-Charvet L, Tall AR. Apoe regulates hematopoietic stem cell proliferation, monocytosis, and monocyte accumulation in atherosclerotic lesions in mice. J Clin Invest. 2011; 121:4138-4149

7. Swirski FK, Nahrendorf M. Leukocyte behavior in atherosclerosis, myocardial infarction, and heart failure. Science. 2013; 339:161-166

8. Swirski FK, Nahrendorf M, Etzrodt M, Wildgruber M, Cortez-Retamozo V, Panizzi P, Figueiredo JL, Kohler RH, Chudnovskiy A, Waterman P, Aikawa E, Mempel TR, Libby P, Weissleder R, Pittet MJ. Identification of splenic reservoir monocytes and their deployment to inflammatory sites. Science. 2009; 325:612-616

9. Dutta P, Courties G, Wei Y, Leuschner F, Gorbatov R, Robbins CS, Iwamoto Y, Thompson B, Carlson AL, Heidt T, Majmudar MD, Lasitschka F, Etzrodt M, Waterman P, Waring MT, Chicoine AT, van der Laan AM, Niessen HW, Piek JJ, Rubin BB, Butany J, Stone JR, Katus HA, Murphy SA, Morrow DA, Sabatine MS, Vinegoni C, Moskowitz MA, Pittet MJ, Libby P, Lin CP, Swirski FK, Weissleder R, Nahrendorf M. Myocardial infarction accelerates atherosclerosis. Nature. 2012; 487:325-329

10. Ishimori T, Saga T, Mamede M, Kobayashi H, Higashi T, Nakamoto Y, Sato N, Konishi J. Increased (18)f-fdg uptake in a model of inflammation: Concanavalin a-mediated lymphocyte activation. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2002; 43:658-663

11. Meller J, Sahlmann CO, Scheel AK. 18f-fdg pet and pet/ct in fever of unknown origin. Journal of nuclear medicine : official publication, Society of Nuclear Medicine. 2007; 48:35-45

pip c analysy is sugggggegegegegegegeststsssss i

Han SSSSSSS, , WeWeWWWWW lclclllll h hhhhhh CLCLCLCLCLCLCL, WWWWWaWaWansporrrrrrrtetetetetetetersrsrsrsrsrsrs aaaaaaandndndndndndnd hhhhhhhdldldldldldldl sssssug

mbbins CS, Chudnovskiy A, Rauch PJ, Figueiredo JL, Iwamoto Y, Gorbatov R, E

oe cnrru uth l ti l i i i J Cli I t 2011 121 4138 4149

matooootopopopopopoieieeieetititititic cc stemememee cell proliferation. Sciencncnccce... 2010; 328:161 899999--1- 693bbbibbb nnnnsn CS, CCChuhuhudndd ovvovskskkiyiyiyyy AAA, RaRaRaucucch h PJPJJ, Figugugueireeedododo JJJL,L,L IIwawaamomomoto YYY,,, GoGoGoGG rbbbatata ovovov RRR, EWWWWWeeebee er GF, UUUeeno TT, vanaanaa Rooijjjenn NNN, MMMulllligagagan-n-n-nn KeKKKK hoee MMMJ,,, LLLiLL bbbb y P,P,P, NNNaaahreennndoetttt MMMMMJ, Weiiisssss leeedder RR, Swiwiwiwiwirsrrrr kiii FFFFFK.K.K.KK Exxxtxx rrrammmeduduuuullllllara yyyyy hhemamaatopopopoiesssiss ss s ss geneneeeneraaatetetes lyyy--6cnocytettett ss thththththat iiiiinfffilililltttrt ttate atherosclerotititititic lllesiiiions. CiCiCiCiCirc llllulatioiiii n. 2020201121 ; 12121121 55:555 3666444-37373777444 rphy AJ, Akhthtttaara i i i M,M,MM, TTTTolololanananiiiii S,SS,S,S PPPPPagagagagaglellelerrr TTTTT, ,,,, BiBBB jl NNNNN,, KuKuKuKuK o o CLCLCLCL, WaWWWW ng M, Sansrramowicz S, , Welcll h hh C,, Bochehh m AE, , Kuivenhoven JA, , Yvvvanananaa -Chaaarvrvrvrr et L,, Tall ARulates hemamamamamatototototopopoppopoieieiiietitititit c c c stststttememememem ccccceleelelll ll ll prprprprprolololololiffiffiferererererataataatioioioioion,n,nn,n mmmonononnonocoocococytytyyty osoososo isisisisis,, ananananand d dd d momomomomonononononocycycycycytetttt accumuhhth lll tiii lll iii iii iii JJJ ClClCli III t 202020111111 121212111 414141383838 444141414999 by guest on June 5, 2018

http://circimaging.ahajournals.org/

Dow

nloaded from

Page 14: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

14

12. Chen IY, Wu JC. Cardiovascular molecular imaging: Focus on clinical translation. Circulation. 2011; 123:425-443

13. Fifer KM, Qadir S, Subramanian S, Vijayakumar J, Figueroa AL, Truong QA, Hoffmann U, Brady TJ, Tawakol A. Positron emission tomography measurement of periodontal 18f-fluorodeoxyglucose uptake is associated with histologically determined carotid plaque inflammation. J Am Coll Cardiol. 2011; 57:971-976

14. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007; 50:2173-2195

15. Surti S, Kuhn A, Werner ME, Perkins AE, Kolthammer J, Karp JS. Performance of philips gemini tf pet/ct scanner with special consideration for its time-of-flight imaging capabilities. J Nucl Med. 2007; 48:471-480

16. Bural GG, Torigian DA, Chen W, Houseni M, Basu S, Alavi A. Increased 18f-fdg uptake within the reticuloendothelial system in patients with active lung cancer on pet imaging may indicate activation of the systemic immune response. Hell J Nucl Med. 2010; 13:23-25

17. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000; 342:836-843

18. Ridker PM, Rifai N, Stampfer MJ, Hennekens CH. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000; 101:1767-1772

19. Libby P. Inflammation in atherosclerosis. Nature. 2002;420:868-874 20. Whitman SC, Ravisankar P, Daugherty A. Interleukin-18 enhances atherosclerosis in

apolipoprotein e(-/-) mice through release of interferon-gamma. Circ Res. 2002; 90:E34-38

21. Mallat Z, Besnard S, Duriez M, Deleuze V, Emmanuel F, Bureau MF, Soubrier F, Esposito B, Duez H, Fievet C, Staels B, Duverger N, Scherman D, Tedgui A. Protective role of interleukin-10 in atherosclerosis. Circ Res. 1999; 85:e17-24

22. Mullick AE, Tobias PS, Curtiss LK. Modulation of atherosclerosis in mice by toll-like receptor 2. J Clin Invest. 2005; 115:3149-3156

23. Lehr HA, Sagban TA, Ihling C, Zahringer U, Hungerer KD, Blumrich M, Reifenberg K, Bhakdi S. Immunopathogenesis of atherosclerosis: Endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet. Circulation. 2001; 104:914-920

24. Assmus B, Iwasaki M, Schachinger V, Roexe T, Koyanagi M, Iekushi K, Xu Q, Tonn T, Seifried E, Liebner S, Kranert WT, Grunwald F, Dimmeler S, Zeiher AM. Acute myocardial infarction activates progenitor cells and increases wnt signalling in the bone marrow. Eur Heart J. 2012; 33:1911-1919

25. Lupi A, Todeschini G, Zanco P. Diffuse metabolic activation of reticuloendothelium on f-18 fdg pet imaging in a case of visceral leishmania. Clin Nucl Med. 2006; 31:34-36

26. Nishiyama Y, Yamamoto Y, Dobashi H, Kameda T. Clinical value of 18f-fluorodeoxyglucose positron emission tomography in patients with connective tissue disease. Jpn J Radiol. 2010; 28:405-413

27. Walter MA, Melzer RA, Schindler C, Muller-Brand J, Tyndall A, Nitzsche EU. The value of [18f]fdg-pet in the diagnosis of large-vessel vasculitis and the assessment of activity and extent of disease. Eur J Nucl Med Mol Imaging. 2005; 32:674-681

28. Panizzi P, Swirski FK, Figueiredo JL, Waterman P, Sosnovik DE, Aikawa E, Libby P,

rrrrrrrotototototototeieieieieieiein n nnnnn ananananananand dd d d d d otototototototheheheheheheherrr r rr r mamamammmam rkrkkkkkkomen.n NNNNNN N EEEnEEEEn lglglllll JJJJJJJ MMMMMMMededededededed.

k eu

0b

o0

lit B D H Fi t C St l B D N S h D T d i A P

kerrrrer PPPPPM,MMMM RRRRRifii aiiiii NNN, Stampfer MJ, Hennekekekeeensnsnsnn CH. Plasmamm conononono centration of interletthttht eeee e risk off f fufufututut reere mmmyoyoyoyy cacaardrdrdiaiaial inininfaf rcrcctitiion aaamomoongngng aaapppppparaarenenntltltlyy y healalalthththy yy yy mememen.n.n. CiCiCircrr u

000000; 101 1:1767-1117772by yy P.P.P.PP Inflaammmmmmm attionnn iin aaaaathththththereeee osssssclcccc erereree ooso isissss. Naaatuuureeeee. 2200200200 ;4;4; 200:8686868-8887474747474 itman SCSCSCSCSC, RaRRRR iiviiisa kknkkkar PPPPP, ,,, DDaDDD ughhhehh ttrttty A.AAA IIInte llrllleukkkikk n-18181888 e hhnhhances athehhh rosclllerolipoprotein e(-/-/-/-/ )))) mimimmim cecece ttthrhrhhrouououghghghghgh rrrrrellelleleaeaeaaasesese ooof ff inininininteteterfr ererrononn-gg-gggamamammamama.. CiCiCiCiCircrcr Res. 2002; 90

llat Z, BeeBeeesnsnnsnnararrarrd dd S,S,SS,S DDDururuuru iezezezezez MMMMM,, DeDeDDeD lelelelleuzuzuzuzuze ee e e V,VV,VV, EEEEEmmmmmmmmmmanaanana ueueueueuelllll F,F,FF,F BBBBBururururureaeaeaeaeau uu uu MFMMMM , Soubiiit BBB DDD HHH FiFiFi t CCC SSSt lll BBB DDD NNN SSS hhh DDD TTT ddd iii AAA PPP by guest on June 5, 2018

http://circimaging.ahajournals.org/

Dow

nloaded from

Page 15: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

15

Pittet M, Weissleder R, Nahrendorf M. Impaired infarct healing in atherosclerotic mice with ly-6c(hi) monocytosis. J Am Coll Cardiol. 2010; 55:1629-1638

by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 16: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

16

Table 1. Baseline characteristics of study subjects. AMI (n=32) CSA (n=33) Control (n = 25) p-value

Age, yrs 56.9±11.6a 61.2±11.5a 57.1±7.5a 0.206

Men 21 (65.6)a 24 (72.7)a 6 (24.0) <0.001

BMI (kg/m2) 24.6±2.6a,b 26.0±4.0b 23.5±2.9a 0.022 WC (cm) 83.4±16.3 92.3±11.4 80.9±7.5 <0.001 Hypertension 15 (46.9)a 19 (57.6)a 1 (4.0) <0.001

Diabetes 13 (40.6)a 13 (39.4) a 2 (8.0) 0.013

Dyslipidemia 19 (59.4)a 16 (48.5)a 2 (8.0) <0.001

Smoking 13 (40.6)a 13 (39.4)a 2 (8.0) 0.013

Statin use 9 (28.1)a 11 (33.3)a 0 (0) 0.006

Total cholesterol, mg/dL 187±44 a 156±35 189±25 a 0.001

Triglycerides, mg/dL 137±142 a, b 160±100 a 87±44 b 0.009

88 (58-168) 113 (85-254) 68 (56-122)

HDL-cholesterol, mg/dL 45±12 a 49±15 a 59±16 0.001

LDL-cholesterol, mg/dL 124±42 a 92±30 115±24 a 0.001

HbA1c, % 6.9±2.1a 7.0±1.6a 5.7±0.4 0.001

6.1 (5.7-7.8) 6.6 (5.7-7.5) 5.6 (5.4-5.9)

WBC, x103/uL 10.9±3.3 6.5±1.2 5.0±1.3 <0.001

10.6 (8.4-12.6) 6.5 (5.5-7.7) 5.0 (3.9-6.3) hsCRP, mg/L 3.48±3.10 1.53±1.55 0.55±0.57 <0.001 1.88 (1.05-5.97) 1.16 (0.32-2.49) 0.41 (0.17-0.82) peak CK-MB, ng/mL 145.6±127.3 - - - peak troponin-T, ng/mL 3.66±4.64 - - -

TBR

Carotid artery 2.13±0.42 1.36±0.37a 1.16±0.09a <0.001

SUV Spleen 2.57±0.39 2.03±0.35 1.54±0.26 <0.001 Bone marrow 1.67±0.16 1.22±0.62 0.80±0.44 <0.001

Data are expressed as mean ± SD; median with interquartile range in parenthesis; or number with percentage in parentheses. P-values represent overall differences across groups as determined by ANOVA or the Kruskal-Wallis test for continuous variables and Pearson’s chi-squared test or Fisher’s exact test for categorical variables. a,b The same letters indicate no statistical significance based on Bonferroni’s post-hoc test, or the Mann-Whitney U-test and, or separate Pearson’s chi-squared test or Fisher’s exact test with Bonferroni corrected p values. AMI, acute myocardial infarction; BMI, body mass index; CSA, chronic stable angina; HDL, high density lipoprotein; hsCRP, high sensitivity C-reactive protein; LDL, low density lipoprotein; SUV, standard uptake value; TBR, target-to-background ratio; WBC, white blood cell; WC, waist circumference.

0000000.0.0.0.0.00001010101010101

0000000 0000.00009090909090909

88 (58 168) 113 (85 254) 68 (56 122)

e

3

10.6 (8.4-12.6) 6.5 (5.5-7.7) 5.0 (3.9-6.3)

8888 (58 168) 113 (85 2225455 ) 68 (56 122222222 )

estetettt rrororrol, mg/dLdLdLd 445±122 a 49±15 a 59±±±±±116 0.001

ssttettt rrrorr l, mg/dL 1124±4±±42 a 92±±±3330 1155±±24 a 000.0000111

6.6.6...9±9±9±99 2.2....11111a 77.7 0±00±0±1.1.1.11 66666aaa 5.5....7±7±±±±0.0.0...4444 000 000.0001010100 a

666 1.1111 (((((5.5.55.7-777-7.7.7.77 8)8)8)8)8) 66666.6.6.6 (((5.55.5 7777-7-7-7.5.55.55) ) 5.55.55.6 66 (5(5(5(5( .4.4.4-5-5-555.9.9.999) )) 3/u/uLL 110.0.9±9±3.3.33 66.5.5±1±1.2.2 55.0.0±1±1.3.33 <0.0.000011

1110.0.0.6 66 (8(8(8.4.4.4-1-1-12.2.2.6)6)6) 666.5.5.5 (((5.5.5.5-5-5-7.7.7.7)7)7) 555.0.0.0 (((3.3.3.9-9-9-6.6.6.3)3)3)

by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 17: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

17

Table 2. Spearman correlation analysis between hsCRP level and FDG uptake in the carotid artery, spleen, and BM in the overall study population.

SUV of BM SUV of Spleen hsCRP

TBR of Carotid artery 0.535* 0.663* 0.465*SUV of BM - 0.637* 0.525*SUV of Spleen 0.637* - 0.458*

* p<0.001 BM, bone marrow; hsCRP, high sensitivity C-reactive protein; SUV, standard uptake value; TBR, target-to-background ratio.

by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 18: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

18

Table 3. Multiple linear regression analysis using the carotid artery TBR as a dependent variable.

p R2 R2adjusted

SUV, bone marrow* 0.438 <0.001 0.329 0.245

SUV, bone marrow † 0.395 <0.001 0.378 0.288

SUV, spleen* 0.688 <0.001 0.461 0.394

SUV, spleen † 0.644 <0.001 0.486 0.412

hsCRP* 0.011 0.040 0.192 0.088 *The association with the carotid artery TBR after adjustment for age, sex, waist circumference, hypertension, diabetes, dyslipidemia, smoking, and statin use. †The association with the carotid artery TBR after adjustment for the above covariates and hsCRP. R2

adjusted = 1 – (1- R2)(N-1)/(N-P-1), where R2= sample R-square, p=number of predictors, N=total sample size.

hsCRP, high sensitivity C-reactive protein; SUV, standard uptake value; TBR, target-to-background ratio.

teteeeeees s s ss s s ananananananand d dd d d d hshshshshshshsCRCRCRCRCRCRCRP.P.P.P.P.P.P ctors,,,,,,, NNNNNNN=t=t=t=t=t=t=totototototototalalalalalalal sssssssamamamamamamamplplplplplplple e sisiiiiiizzzzzzz-to-bacacccccckgkgkgkgkgground rararararrratitittittt o.oooooo

by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 19: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

19

Figure Legends

Figure 1. A. Representative examples of maximum-intensity-projection 18F-FDG PET images

showing highly increased uptake and moderately increased uptake throughout the bone marrow

and spleen in patients with acute myocardial infarction (AMI) and chronic stable angina (CSA),

respectively. B. Axial fusion images at the carotid artery level from the same scan showing

diffuse intense uptake of 18F-FDG in the carotid arteries of patients with AMI (arrow) and

moderate uptake in patients with CSA.

Figure 2. Mean differences in spleen SUV (A), BM SUV (B), and the carotid artery TBR (C)

between the 3 study groups. Error bars show 95% confidence intervals of means.

AMI, acute myocardial infarction; BM, bone marrow; CSA, chronic stable angina; SUV,

standard uptake value; TBR, target-to-background ratio.

carootititititititidd dddd ararttttetett ryry TTTTTTTBRBRBRBRBRBRBR (((((((CC

e

p

e 33 stststststudududududy yyyy grgrgrouuuuuppsp . Error bars show 95% cococooonnnfidence interee valslslsll of means.

eeeee mmmmmyocardiall infafafarrctionoonoo ; BMBMM, bbonnene mmarrrrowwwww;;;;; CCCSA,A, chhhrooonicicicii stablblbllle ee aaangiiiinna;

ptake vavaalllull e; TTTTTBRBRBRRR,,, tttarget-tttto-bbabbb ckground r ttatiiioi .

by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 20: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 21: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 22: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

p<0.001

P<0.001

by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 23: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

p<0.001

P=0.002

by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 24: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

p<0.001

P=0.095

by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from

Page 25: The Metabolic Activity of the Spleen and Bone Marrow in ...circimaging.ahajournals.org/content/circcvim/early/2014/01/31/CIRC...The Metabolic Activity of the Spleen and Bone Marrow

Eung Ju Kim, Sungeun Kim, Hong Seog Seo and Dong Oh KangF-FDG PET Imaging18Infarction Evaluated by

The Metabolic Activity of the Spleen and Bone Marrow in Patients with Acute Myocardial

Print ISSN: 1941-9651. Online ISSN: 1942-0080 Copyright © 2014 American Heart Association, Inc. All rights reserved.

TX 75231is published by the American Heart Association, 7272 Greenville Avenue, Dallas,Circulation: Cardiovascular Imaging

published online January 31, 2014;Circ Cardiovasc Imaging. 

http://circimaging.ahajournals.org/content/early/2014/01/31/CIRCIMAGING.113.001093World Wide Web at:

The online version of this article, along with updated information and services, is located on the

  http://circimaging.ahajournals.org//subscriptions/

is online at: Circulation: Cardiovascular Imaging Information about subscribing to Subscriptions: 

http://www.lww.com/reprints Information about reprints can be found online at: Reprints:

  document. Permissions and Rights Question and Answer this process is available in the

located, click Request Permissions in the middle column of the Web page under Services. Further information aboutnot the Editorial Office. Once the online version of the published article for which permission is being requested is

can be obtained via RightsLink, a service of the Copyright Clearance Center,Circulation: Cardiovascular Imaging Requests for permissions to reproduce figures, tables, or portions of articles originally published inPermissions:

by guest on June 5, 2018http://circim

aging.ahajournals.org/D

ownloaded from